Disease | glioma |
Comorbidity | C0007131|nsclc |
Sentences | 1 |
PubMedID- 22588882 | At equivalent doses, erlotinib achieved lower kinase-site occupancy in glioma-derived egfrviii compared with nsclc-derived egfr mutants. |
Page: 1